Article
Iran War Puts Ukraine Peace Talks On Hold, As Gulf Venue Under Attack
Iran War Puts Ukraine Peace Talks On Hold, As Gulf Venue Under Attack
The Russia-Ukraine war, having just last month entered its fifth year, continues experiencing spillover effects from the Trump-ordered Operation Epic Fury in Iran. Ukrainian President Volodymyr Zelensky has newly announced (overnight) that trilateral peace talks with Russia and the United States are on hold due to the Iran war.
In his nightly address, Zelensky said Ukraine remains in constant contact with Washington but the diplomatic process has paused: "We continue to engage with the United States practically on...
aboutLiberty Portal
Liberty Portal is your gateway for free markets and free thinking. We aggregate open-sourced content to promote and popularize important people and lessons within the liberty movement.
suggested
Mar 19, 2026 / Dave DeCamp
US F-35 Fighter Jet Damaged by Iranian Fire
The US military said on Thursday that a US F-35 fighter jet was damaged by suspected Iranian fire while operating over Iran and was forced to make an emergency landing. “The aircraft landed safely, and the pilot is in stable condition,” said Capt. Tim Hawkins, a spokesman for US Central Command. “This incident is under […]
Read more
Mar 8, 2026 / Tyler Durden
A 'War Of The Oil Refineries' Opens As Israel Bombs Key Tehran Sites, After Which Haifa Refinery Targeted
A 'War Of The Oil Refineries' Opens As Israel Bombs Key Tehran Sites, After Which Haifa Refinery Targeted
Update(1425): Is a tit-for-tat oil depot war opening? This could be the next phase of escalation, already in progress.
Iran's Islamic Revolutionary Guard Corps (IRGC) says it has struck Israel's Haifa refinery, framing the attack as direct retaliation for fresh Israeli strikes on energy infrastructure inside Iran.
The war of the oil refineries: Iran says it targeted tonight a refinery in Israel after an attack on its own refinery in Tehran.
The regional energy infrastructure is getting...
Read more
Feb 23, 2026 / Tyler Durden
"Worst-Case Scenario": Novo Nordisk Plunges After Next-Gen Obesity Drug Falls Short Of Lilly Rival
"Worst-Case Scenario": Novo Nordisk Plunges After Next-Gen Obesity Drug Falls Short Of Lilly Rival
Shares of Novo Nordisk A/S plummeted again on Monday after the company reported trial results showing its next-generation obesity shot, CagriSema, delivered 20.2% weight loss at 84 weeks, compared to 23.6% for Eli Lilly & Co.’s tirzepatide (Zepbound).
Bloomberg Intelligence analyst Michael Shah explained, "This outcome is the worst-case scenario for Novo and heightens the need for M&A with Novo’s other GLP-1/Amylin drug."
Shares of Novo in Copenhagen plunged as much as 16.5%, breaking below a support level...
Read more




